Loading...

FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
128005 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128006 500 µg 235€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  2. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  3. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  4. Zaman R, et al. 2021. Immunity. :. PubMed
  5. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  6. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  7. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  8. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  9. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  10. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  11. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  12. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  13. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  14. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  15. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  16. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  17. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  18. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  19. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  20. Dong L, et al. 2021. Cancer Cell. . PubMed
  21. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  22. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  23. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  24. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  25. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  26. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  27. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  28. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  29. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  30. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  31. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  32. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  33. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  34. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  35. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  36. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  37. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  38. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  39. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  40. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  41. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  42. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  43. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  44. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  45. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  46. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  47. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  48. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  49. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  50. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  51. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  52. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  53. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  54. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  55. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  56. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  57. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  58. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  59. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  60. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  61. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  62. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  63. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  64. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  65. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  66. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  67. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  68. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  69. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  70. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  71. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  72. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  73. He J, et al. 2019. J Clin Invest. 130. PubMed
  74. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  75. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  76. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  77. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  78. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  79. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  80. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  81. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  82. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  83. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  84. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  85. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  86. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  87. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  88. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  89. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  90. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  91. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  92. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  93. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  94. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  95. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  96. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  97. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  98. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  99. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  100. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  101. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  102. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  103. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  104. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  105. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  106. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  107. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  108. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  109. Tang S, et al. 2022. Virol J. 19:32. PubMed
  110. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  111. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  112. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  113. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  114. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  115. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  116. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  117. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  118. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  119. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  120. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  121. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  122. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  123. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  124. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  125. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  126. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  127. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  128. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  129. Jones GS, et al. 2020. mSphere. 5:. PubMed
  130. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  131. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  132. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  133. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  134. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  135. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  136. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  137. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  138. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  139. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186135 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12.09.2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Pacific Blue™ anti-mouse Ly-6C

  • APC anti-mouse Ly-6C

  • Purified anti-mouse Ly-6C

  • Biotin anti-mouse Ly-6C

  • FITC anti-mouse Ly-6C

  • Alexa Fluor® 647 anti-mouse Ly-6C

  • PE anti-mouse Ly-6C

  • PerCP/Cyanine5.5 anti-mouse Ly-6C

  • PE/Cyanine7 anti-mouse Ly-6C

  • Alexa Fluor® 488 anti-mouse Ly-6C

  • Alexa Fluor® 700 anti-mouse Ly-6C

  • APC/Cyanine7 anti-mouse Ly-6C

  • PerCP anti-mouse Ly-6C

  • Brilliant Violet 570™ anti-mouse Ly-6C

  • Brilliant Violet 421™ anti-mouse Ly-6C

  • Brilliant Violet 510™ anti-mouse Ly-6C

  • Brilliant Violet 605™ anti-mouse Ly-6C

  • Brilliant Violet 711™ anti-mouse Ly-6C

  • Purified anti-mouse Ly-6C (Maxpar® Ready)

  • Brilliant Violet 785™ anti-mouse Ly-6C

  • PE/Dazzle™ 594 anti-mouse Ly-6C

  • APC/Fire™ 750 anti-mouse Ly-6C

  • TotalSeq™-A0013 anti-mouse Ly-6C

  • Brilliant Violet 650™ anti-mouse Ly-6C

  • TotalSeq™-C0013 anti-mouse Ly-6C

  • TotalSeq™-B0013 anti-mouse Ly-6C

  • APC/Fire™ 810 anti-mouse Ly-6C Antibody
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account